Clinical case of Rosai—Dorfman disease
Regenerative biotechnologies, preventive, digital and predictive medicine · 16.06.2026 · 3 (2) · 34
DOI: 10.17116/rbpdpm2026302134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative biotechnologies, preventive, digital and predictive medicine, erschienen am 16.06.2026. Verfasst von E.V. Filatova und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Different specialists face various complications in patients with previous COVID-19 infection. Such long-term complications include the growth of lymphoid tissue, including the Pirogov—Waldeyer rings, and cervical lymph node enlargement.
Zitieren
APA
Filatova, E., Khrykova, A., & Ivanova, I. (2026). Clinical case of Rosai—Dorfman disease. Regenerative biotechnologies, preventive, digital and predictive medicine, 3(2), 34. https://doi.org/10.17116/rbpdpm2026302134
Vancouver
Filatova E, Khrykova A, Ivanova I. Clinical case of Rosai—Dorfman disease. Regenerative biotechnologies, preventive, digital and predictive medicine. 2026;3(2):34. doi:10.17116/rbpdpm2026302134
BibTeX
@article{Filatova2026,
author = {Filatova, E.V. and Khrykova, A.G. and Ivanova, I.I.},
title = {Clinical case of Rosai—Dorfman disease},
journal = {Regenerative biotechnologies, preventive, digital and predictive medicine},
year = {2026},
volume = {3},
number = {2},
pages = {34},
doi = {10.17116/rbpdpm2026302134}
}
EUVIMED